iBio, Inc.
NASDAQ: IBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Martin Brenner
- Employees
- 16
- Headquarters
- Bryan, United States
- IPO year
- 2008
- Market cap
- $25.6M
- Website
- https://www.ibioinc.com
Loading IBIO…
Loading profile data…Frequently asked questions about IBIO
What does iBio, Inc. (IBIO) do?
iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing. The company's leading therapeutic candidate, IBIO-100, is currently progressing through in...
Where does IBIO trade?
iBio, Inc. (IBIO) trades on the NASDAQ Capital Market.
What sector is IBIO in?
iBio, Inc. (IBIO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of iBio, Inc.?
Martin Brenner is the chief executive officer of iBio, Inc. (IBIO).
Where is iBio, Inc. headquartered?
iBio, Inc. is headquartered in United States.
Does IBIO pay a dividend?
iBio, Inc. (IBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IBIO go public?
iBio, Inc. (IBIO) completed its initial public offering in 2008.